title: Dramatic regression of recalcitrant human papillomavirus type 1-related palmar verrucae and squamous cell carcinoma in situ following R-CHOP chemotherapy and transition to sirolimus in a renal transplant patient with diffuse large B cell lymphoma.
authors.affiliation: Department of Dermatology, University of Illinois, Chicago, IL, USA.
authors.forename: Karl K
authors.initials: KK
authors.lastname: Vance
authors.forename: Aleksandar L
authors.initials: AL
authors.lastname: Krunic
authors.forename: Patricia M
authors.initials: PM
authors.lastname: Fishman
authors.forename: Shrihari S
authors.initials: SS
authors.lastname: Kadkol
authors.forename: Gerard J
authors.initials: GJ
authors.lastname: Nuovo
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000150:complications / Q000188:drug therapy*; D011183:Postoperative Complications / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D012074:Remission Induction; D000069283:Rituximab; D020123:Sirolimus / Q000627:therapeutic use*; D012871:Skin Diseases / Q000150:complications / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use; D014860:Warts / Q000150:complications / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone; D020123:Sirolimus